Bristol Myers Squibb Co. (BMY)
62.37
+1.27
(+2.08%)
USD |
NYSE |
Feb 27, 16:00
62.38
+0.01
(+0.02%)
After-Hours: 20:00
Bristol Myers Squibb EPS Diluted (Quarterly) : 0.5326 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Gilead Sciences, Inc. | 1.742 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Janux Therapeutics, Inc. | -0.514 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.086B |
| Revenue (Quarterly) | 12.50B |
| Total Expenses (Quarterly) | 11.42B |
| Enterprise Value | 163.51B |
| Gross Profit Margin (Quarterly) | 66.24% |
| Profit Margin (Quarterly) | 8.69% |
| Earnings Yield | 5.55% |
| Operating Earnings Yield | 11.88% |
| Normalized Earnings Yield | 9.236 |